Germany

3.8.2022

MVision’s GBS™ is Featured in 5 Posters at the German Society of Radiation Oncology (DEGRO) Annual Meeting

This week, we're focusing on high-impact research presented during the German Society of Radiation Oncology (DEGRO) Annual Meeting. Five posters included a focus on MVision’s guideline-based segmentation, GBS™, solution (also available as an on-premise solution).   Development of an AI-based auto-contouring of upper and lower jaw segments for optimized radiation planning…

News

29.12.2021

2021 MVision AI Re-cap: The Year of GCAIS™

2021 is an innovative and  foundational year for MVision AI. We are proud of what we have accomplished so far and super excited about what is in store for us in the future. One feeling that stands out as we look back at 2021 is gratitude. We thank everyone who…

News

21.9.2021

New Horizons for Patients with Endometrial Cancer

September is Uterine Cancer Awareness Month. Raising awareness is very close to the MVisionaries since uterine cancer is the fourth most common cancer for women. It is estimated that 66,570 people in the United States alone will be diagnosed with uterine cancer this year. 90% of uterine cancers are endometrioid…

News

16.7.2021

What is the radiotherapy process really like?

Did you know that more than 60% of cancer patients will receive radiation therapy, a local treatment that is based on the use of ionizing radiation to cause damage to tumor cells and prevent the growth and proliferation, at some point in the treatment? The quality and atmosphere of radiotherapy…

News

Our Newsletter

Subscribe to get information, latest news and other interesting offers about MVision AI